The Scientist

» pharma and culture

Most Recent

image: Hearing Help

Hearing Help

By | September 1, 2015

For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.  

2 Comments

image: Study: Short Headlines Get More Citations

Study: Short Headlines Get More Citations

By | August 27, 2015

Scientific journals that publish papers with snappier titles accrue more citations per paper, according to a report.

0 Comments

image: Opinion: Making Progress by Slowing Down

Opinion: Making Progress by Slowing Down

By | August 24, 2015

Academic research could be strengthened by thinking more and doing less.

5 Comments

image: Valeant Scoops Sprout for $1 Billion

Valeant Scoops Sprout for $1 Billion

By | August 24, 2015

The Canadian pharmaceutical firm is buying the American drugmaker behind the newly approved “female Viagra.”

0 Comments

image: Legionnaires’ Bacteria at GSK

Legionnaires’ Bacteria at GSK

By | August 14, 2015

GlaxoSmithKline temporarily shuts down a manufacturing plant in North Carolina after Legionella bacteria are detected in two external cooling towers.

0 Comments

image: Book Excerpt from <em>Life on the Edge</em>

Book Excerpt from Life on the Edge

By | August 1, 2015

In Chapter 4, “The quantum beat,” authors Johnjoe McFadden and Jim Al-Khalili rethink Newton’s apple from a quantum-biological perspective.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | August 1, 2015

Gods of the Morning, Hedonic Eating, A Beautiful Question, and Genomic Messages

0 Comments

image: Good Vibrations

Good Vibrations

By | August 1, 2015

Does a delicately orchestrated balance between quantum and classical physics distinguish living from nonliving things?

15 Comments

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

Popular Now

  1. Neurons Compete to Form Memories
  2. Mapping the Human Connectome
    Daily News Mapping the Human Connectome

    A new map of human cortex combines data from multiple imaging modalities and comprises 180 distinct regions.

  3. The Genetic Components of Rare Diseases
  4. Classic Example of Symbiosis Revised
RayBiotech